Literature DB >> 2423458

Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A.

J K Chia, M Pollack, D Avigan, S Steinbach.   

Abstract

Monoclonal antibodies (MAbs) are described which react with two discrete structural domains of Pseudomonas aeruginosa toxin A and which have two distinct functional profiles. The MAbs designated T3-1C7 and T4-1F2 reacted with a 46,000-dalton peptide similar to the putative B or binding fragment of toxin A. These antibodies neutralized the cytotoxic and lethal properties of toxin but had no effect on its ADP-ribosyl transferase activity. T4-1F2 interfered with the binding of toxin A to membrane receptors on mouse fibroblasts (L cells), although the epitope for the antibody appears to be distinct from the actual receptor binding site. The MAb designated T2-1H2 reacted with intact toxin A and with a cloned, enzymatically active carboxy-terminal polypeptide similar to the toxin A fragment. This MAb neutralized the ADP-ribosyl transferase activity of activated holotoxin and of the cloned peptide, but inhibited neither binding of toxin to membrane receptors nor its cytotoxic and lethal actions. The complementary specificity and function of these MAbs confirm the functional specialization of discrete structural domains within the toxin A molecule. Our findings suggest the greater antitoxic potential of antibodies that block binding, compared with those which inhibit the enzymatic activity of toxin A.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423458      PMCID: PMC260923          DOI: 10.1128/iai.52.3.756-762.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  28 in total

1.  An immunological study of the diphtheria toxin molecule.

Authors:  A M Pappenheimer; T Uchida; A A Harper
Journal:  Immunochemistry       Date:  1972-09

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Purification and characterization of Pseudomonas aeruginosa exotoxin.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

4.  Exotoxins of Pseudomonas aeruginosa. II. Concentration, purification, and characterization of exotoxin A.

Authors:  P V Liu; S Yoshii; H Hsieh
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

5.  Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

6.  Pseudomonas aeruginosa exotoxin: effect on cell cultures.

Authors:  O R Pavlovskis; F B Gordon
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

7.  Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa.

Authors:  S H Leppla
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo.

Authors:  B H Iglewski; P V Liu; D Kabat
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

10.  Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa.

Authors:  G L Gray; D H Smith; J S Baldridge; R N Harkins; M L Vasil; E Y Chen; H L Heyneker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 12.779

View more
  7 in total

1.  Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin.

Authors:  S F Little; S H Leppla; A M Friedlander
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  A human-human hybridoma secreting anti-Pseudomonas aeruginosa exotoxin-A monoclonal antibody with highly potent neutralizing activity.

Authors:  M Kuriyama; Y Ichimori; S Iwasa; K Tsukamoto
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.040

3.  Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin.

Authors:  D M Roscoe; S H Jung; I Benhar; L Pai; B K Lee; I Pastan
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.609

4.  Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A.

Authors:  H S Elzaim; A K Chopra; J W Peterson; R Goodheart; J P Heggers
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.609

5.  Characterization of monoclonal antibody B7, which neutralizes the cytotoxicity of Pseudomonas aeruginosa exotoxin A.

Authors:  H F Shang; M L Yeh; C P Lin; J Hwang
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

6.  Binding of monoclonal antibody specific for domain Ia/II of Pseudomonas aeruginosa exotoxin A at pH 4 strongly neutralizes exotoxin A-induced cytotoxicity in cell culture and in vivo.

Authors:  H Ohtsuka; K Horigome; A Higuchi; N Nomura; H Ochi; S Yokota; T Kohzuki; H Noguchi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.609

7.  Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies.

Authors:  H S El-Zaim; A K Chopra; J W Peterson; M L Vasil; J P Heggers
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.